VASCULAR ENDOTHELIAL GROWTH FACTOR 2

Details for Australian Patent Application No. 2002313770 (hide)

Owner HUMAN GENOME SCIENCES, INC.

Inventors ROSEN, Graig, A.; ALBERT, Vivian, R.; RUBEN, Steven, M.; WAGER, Ruth, E.

Pub. Number AU-A-2002313770

PCT Number PCT/US02/26246

PCT Pub. Number WO2003/097660

Priority PCT/US02/11474 12.04.02 US

Filing date 19 August 2002

Wipo publication date 2 December 2003

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 014/00 Peptides having more than 20 amino acids

C07K 016/22 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): PCT/US02/11474 12.04.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2002313770

6 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002313771-RETROVIRUS ISOLATED FROM MANTLE HISTIOCYTES IN MANTLE CELL LYMPHOMA

2002313769-RNA SILENCING SUPPRESSION